These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A case of juvenile hepatocellular carcinoma associated with liver cirrhosis in a family clustering of HBs antigen carriers and liver diseases. Nunoda S, Mimo N, Kitano H, Kyoi M, Hifumi S, Ueno T, Takeda R, Nakanuma Y. Am J Gastroenterol; 1983 May; 78(5):301-4. PubMed ID: 6303115 [Abstract] [Full Text] [Related]
24. Alpha 1-antitrypsin in patients with hepatocellular carcinoma and chronic active hepatitis. Fargion S, Klasen EC, Lalatta F, Sangalli G, Tommasini M, Fiorelli G. Clin Genet; 1981 Feb; 19(2):134-9. PubMed ID: 6258829 [Abstract] [Full Text] [Related]
29. Abnormality of Wnt3a expression as novel specific biomarker for diagnosis and differentiation of hepatocellular carcinoma. Pan L, Yao M, Zheng W, Gu J, Yang X, Qiu L, Cai Y, Wu W, Yao D. Tumour Biol; 2016 Apr; 37(4):5561-8. PubMed ID: 26577850 [Abstract] [Full Text] [Related]
30. [Alpha 1-antitrypsin deficiency and the liver (author's transl)]. Spech HJ, Liehr H. Z Gastroenterol; 1982 Jul; 20(7):393-404. PubMed ID: 6287750 [Abstract] [Full Text] [Related]
32. Primary carcinoma of the liver (hepatoma) in Rhodesia: a clinical study. Gelfand M, Castle WM, Buchanan WM. S Afr Med J; 1972 Apr 29; 46(18):527-32. PubMed ID: 4338403 [No Abstract] [Full Text] [Related]